| The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration ER Perri, CJ Thomas, S Parakh, DM Spencer, JD Atkin Frontiers in cell and developmental biology 3, 80, 2016 | 179 | 2016 |
| Redox regulation in amyotrophic lateral sclerosis S Parakh, DM Spencer, MA Halloran, KY Soo, JD Atkin | 101 | 2013 |
| DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair DMS Spencer, RA Bilardi, TH Koch, GC Post, JW Nafie, KI Kimura, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 638 (1 …, 2008 | 98 | 2008 |
| Extracellular wildtype and mutant SOD1 induces ER–Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells V Sundaramoorthy, AK Walker, J Yerbury, KY Soo, MA Farg, V Hoang, ... Cellular and molecular life sciences 70, 4181-4195, 2013 | 92 | 2013 |
| Caspase-2: controversial killer or checkpoint controller? T Kitevska, DMS Spencer, CJ Hawkins Apoptosis 14, 829-848, 2009 | 58 | 2009 |
| ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis S Parakh, CJ Jagaraj, M Vidal, AMG Ragagnin, ER Perri, A Konopka, ... Human molecular genetics 27 (8), 1311-1331, 2018 | 30 | 2018 |
| Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance. SM Cutts, A Nudelman, V Pillay, DM Spencer, I Levovich, A Rephaeli, ... Oncology research 15 (4), 199-213, 2005 | 25 | 2005 |
| The redox activity of protein disulfide isomerase inhibits ALS phenotypes in cellular and zebrafish models S Parakh, S Shadfar, ER Perri, AMG Ragagnin, CV Piattoni, MB Fogolín, ... Iscience 23 (5), 2020 | 22 | 2020 |
| Barminomycin, a model for the development of new anthracyclines K Kimura, DMS Spencer, R Bilardi, LP Swift, AJ Box, RTC Brownlee, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2010 | 8 | 2010 |
| Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models S Parakh, ER Perri, M Vidal, J Sultana, S Shadfar, P Mehta, A Konopka, ... Scientific Reports 11 (1), 17557, 2021 | 7 | 2021 |
| Detection of labile anthracycline-DNA adducts by real-time PCR DMS Spencer, SM Cutts, K Ki, PJ Gray, DR Phillips Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 13 …, 2003 | 4 | 2003 |
| Cellular Responses to Anthracycline-DNA Adducts DMS Spencer La Trobe University, 2007 | 1 | 2007 |
| Assessing competence in numeracy skills in molecular biology students J Pakay, D Spencer Proceedings of The Australian Conference on Science and Mathematics Education, 2013 | | 2013 |
| P310 PROTEIN DISULPHIDE ISOMERASE IS PROTECTIVE AGAINST MUTANT SOD1, TDP-43 AND FUS PATHOLOGY IN AMYOTROPHIC LATERAL SCLEROSIS S PARAKH, D SPENCER, J SULTANA, KY SOO, N BILLA, AL HELWANI, ... THEME 11 THERAPEUTIC STRATEGIES 14 (2), 230, 2013 | | 2013 |
| Negotiating new research identities through the Graduate Certificate in Higher Education S Barradell, S Down, D Spencer, T Peseta La Trobe, 2012 | | 2012 |
| Identifying the repair pathway for adriamycin-dna damage D Phillips, S Cutts, DMS Spencer ComBio 2005, Adelaide, SA.,, 2005 | | 2005 |
| Cellular repair of DNA-anthracycline adducts DM Spencer, SM Cutts, KI Kimura, A Rephaeli, A Nudelman, DR Phillips Cancer Research 64 (7 Supplement), 1242-1243, 2004 | | 2004 |
| Cellular repair of DNA-anthracycline adducts D Phillips, A Nudelman, A Rephaeli, K Kimura, S Cutts, DMS Spencer [Sl]:[sn],, 2004 | | 2004 |
| Mutation Analysis of doxorubicin-DNA adducts D Phillips, M Cullinane, S Cutts, DMS Spencer [Sl]:[sn],, 2004 | | 2004 |
| Cellular Targets of Formaldehyde-activated Adriamycin D Phillips, A Nudelman, A Rephaeli, LP Swift, S Cutts, DMS Spencer Toronto, Ontario, Canada: Conference Organizing Committee,, 2003 | | 2003 |
